Sixth edition of Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.
In ALLG News Edition 6, you can read about progress in blood cancer treatment, the future of clinical trials, the role trial coordinators play in improving cancer care, and learn the latest in [...]
Introducing Five of Our Newest Life Members
During the October 2023 Scientific Meeting, ALLG welcomed our five new Life Members: Professor Mark Hertzberg, Professor Paula Marlton, Michele Gambrill, Professor Andrew Grigg and Professor [...]
ALLG Welcomes Professor Mark Hertzberg as New Board Director
Life Member and Order of Australia recipient, Professor Mark Hertzberg was recently appointed as our new Board Director.
Crunching the numbers from our 50th Anniversary ALLG Scientific Meeting
On Friday 27 October we wrapped up our bumper 50th Anniversary ALLG Scientific Meeting.
Congratulations to our 2023 Hall of Fame winners!
We’ve been eagerly awaiting the chance to announce who has been inducted into the ALLG Annual Hall of Fame this year. At our 50th anniversary Gala dinner last night at Crown Sydney, we [...]
ALLG’s October Scientific Meeting week is here!
You could say that this year’s ALLG October Scientific Meeting week has been 50 years in the making. Tomorrow, we are looking forward to welcoming record number of ALLG Members to open this very [...]
5 Decades of Clinical Trials Impact: Look at how far we’ve come!
It’s a very special year at the ALLG. Our collaborative success in clinical trials has laid the foundations for a brighter future for blood cancer patients for over 50 years. There’s a lot to [...]
Join ALLG & Lymphoma Australia’s Patient Education & Engagement Seminar
Calling blood cancer patients and carers in Sydney! Would you like to know more from the experts about wellbeing throughout your treatment journey? Or hear how clinical trials can help you?
Fifth edition of Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.
September is Blood Cancer Month. You can read about ALLG's "5 decades of impact" in blood cancer clinical trials, and the "best results we have ever seen" in Advanced Hodgkin lymphoma from one of [...]
Fourth edition of Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.
The ALLG's Laboratory Science research is helping determine which patients benefit from targeted therapy for their blood cancer. You can read about this and more in our latest quarterly [...]
New online resource enables researchers to access and share data from health studies
The HeSANDA platform is a catalogue of research metadata from clinical trials conducted across Australia that enables researchers to access and share data from health studies. Led by the [...]
ALLG Life Member Dr Ruth Spearing awarded with King’s Honour NZ
Congratulations to ALLG Life Member Dr Ruth Spearing who has been honoured in the 2023 King's Birthday New Zealand and Coronation Honours! Ruth has been made a Companion of the New Zealand Order [...]
ALLG trials at prestigious international conferences
Two ALLG clinical trials, ALL08 BLAM and NHL29 IRIC have been accepted as abstracts with poster presentations at prestigious European scientific conferences.
ALLG featured in The Limbic: “Five decades at the ‘cutting edge’: ALLG turns 50”
ALLG has featured in The Limbic with our Scientific Advisory Committee Chair, Prof Judith Trotman, interviewed about our five decades of impact.
Third edition of Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.
It's our pleasure to share with you the third Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.
Sir Sam Neill – New Zealand actor and blood cancer survivor supports the ALLG’s concerns of proposed NZ bill affecting clinical trials
Sir Sam Neill, New Zealand (NZ) actor and blood cancer survivor supports the ALLG’s concerns of proposed NZ bill affecting clinical trials.
ALLG in the Herald Sun and The Advertiser newspapers – about AML trial and our 50 years of impact
ALLG has featured in the Herald Sun and The Advertiser newspapers with "World first cancer trial" about a novel way to identify and treat patients with acute myeloid leukaemia (AML) before they [...]
Clinical trials in myeloma for better treatments…better lives
Prof Hang Quach, Chair of ALLG's Myeloma Scientific Working Party talks about clinical trials in myeloma for better treatments…better lives.
Latest State of the Nation: Blood Cancer in Australia report
Latest ‘State of the Nation: Blood Cancer in Australia’ report highlights progress and the actions still required to improve outcomes for patients.
March is International #Myeloma Awareness Month
March is International Myeloma Awareness Month; a chance to highlight this relatively rare blood cancer. The ALLG’s Myeloma Scientific Working Party trials new promising drugs to improve [...]
February 28 is Global #RareDiseaseDay
Rare cancers make up 25% of cancers in total, yet 40% of deaths. This matters because many blood cancers are rare. In Australia a rare cancer means they affect fewer than 6 diagnoses per 100, 000 [...]
ALLG Consumer Representative awarded AM for service to people with cancer
Congratulations to ALLG Consumer Representative, Mr John Stubbs AM, who has been appointed a Member of the Order of Australia for ‘significant service to community health, particularly to people [...]
ALLG’s 50th Anniversary Year!
1 January 2023 marks the start of ALLG’s 50th Anniversary year! Since 1973, the ALLG has been conducting clinical trials focused on delivering new treatments and supporting better lives for [...]
Teletrial program allowed Vesselin Petkov to take part in an ALLG clinical trial without being separated from his family
An Australian Teletrial Program (ATP) is working to improve access to clinical trials for people living in rural and regional parts of the country. Vesselin Petkov from Cairns [pictured with his [...]
Second edition of Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.
It's our pleasure to share with you the second Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.
ALLG Member awarded prestigious Metcalf Prize, for Stem Cell Research
ALLG Member, Dr Ashley Ng, a WEHI Clinical Translational Research Fellow, has been awarded the prestigious Metcalf Prize for Stem Cell Research, for "Controlling rogue blood stem cells".
First edition of Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.
It's our pleasure to share with you the first ever Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.
A world first in acute myeloid leukaemia (AML) trials
The ALLG has opened the first hospital site in Australia for a clinical trial that is a world first in acute myeloid leukaemia (AML) trials. The AMLM26 INTERCEPT study aims to radically change [...]
Vale Queen Elizabeth II
Her Majesty the Queen will be remembered for her devotion and commitment to the Commonwealth for many years to come. We pay tribute to the Queen’s 70 years of service. The Queen’s dedication to [...]
ALLG trials BM12, CML12 and LS21 accepted to European Hematology Association (EHA) 2022
The ALLG trial BM12 CAST has been accepted for publication as an abstract at EHA. Congratulations to the Chief Investigators A/Prof David Curtis and Dr Sushrut Patil, and the trial team.